Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

Kocaturk E., Baskan E. B., Engin B., Ozdemir M., Kucuk O. S., Can P., ...More

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.484-485 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 74
  • City: Lisbon
  • Country: Portugal
  • Page Numbers: pp.484-485
  • Hacettepe University Affiliated: Yes